Neurocrine Biosciences
NBIX
#1521
Rank
S$15.22 B
Marketcap
$152.70
Share price
-0.39%
Change (1 day)
-19.59%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

EPS for Neurocrine Biosciences (NBIX)

EPS in 2023 (TTM): $2.67

According to Neurocrine Biosciences 's latest financial reports the company's current EPS (TTM) is $2.63. In 2022 the company made an earnings per share (EPS) of $2.16 an increase over its 2021 EPS that were of $1.27.

EPS history for Neurocrine Biosciences from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.6724.02%
2022$2.1669.47%
2021$1.27-78.21%
2020$5.84990%
2019$0.5481.82%
2018$0.29-113.5%
2017-$2.180.62%
2016-$2.1757.28%
2015-$1.3825.61%
2014-$1.1018.84%
2013-$0.92-1085.71%
2012$0.09376-89.71%
2011$0.91-500%
2010-$0.23-86.92%
2009-$1.74-43.48%
2008-$3.08-57.8%
2007-$7.3092.58%
2006-$3.79371.67%
2005-$0.80-52.76%
2004-$1.7036.56%
2003-$1.25-70%
2002-$4.15118.31%
2001-$1.908.4%
2000-$1.7548.86%
1999-$1.18-20%
1998-$1.47-479.31%
1997$0.39

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.80 6.63%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.74-71.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
-$3.96-251.02%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.27 177.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.93 87.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.49-5.10%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.63-123.98%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.06-254.59%๐Ÿ‡บ๐Ÿ‡ธ USA